CognivyaAI is a pre-seed stage venture building an AI-native governance and decision-support platform for biotech, pharma and regulated healthcare organizations.
Biotech and healthcare teams operate under intense pressure, with multiple stakeholders, strict compliance expectations, and tightly coupled dependencies.
CognivyaAI is built to support execution where quality, traceability, and readiness really matter. Today, many organizations still run critical decisions through a patchwork of Excel, PowerPoint, email, and siloed tools. Regulatory writing, portfolio and board reporting, PMO operations, and vendor payments still rely on manual, one-off efforts.
We’re building the governance and operations layer these teams are missing, so decisions, documents, and spend are all driven from a single, evidence-linked platform.
CognivyaOne©
Our comprehensive platform covers four core areas
These areas are designed to work together through a unified intelligence layer, while maintaining modular architecture for phased adoption with convenience and ease.
Governance & Board Reporting
Portfolio views, stage-gates, and board-ready narratives grounded in operational data
Functional Operations
Pre-clinical, clinical, and regulatory workspaces connected to underlying program data
PMO Operations
Risks, workflows, timelines, dependencies, budgeting & resource management, and execution tracking across complex programs
Payments & Vendor Oversight
Linking contracts, SOWs, and invoices to actual program work and delivery
Together, these capabilities provide leadership a clearer, more consistent view of execution, improving strategic alignment and decision-making across the organization.
Powered by the CognivyaAI Evidence Engine
An evidence-driven intelligence layer engineered for reliable low- hallucination outputs and audit- ready traceability in regulated, high-stakes environments.
Connect with our team
We share additional product context, demonstrations, and technical details through direct conversations with investors and strategic partners.
CognivyaAI is currently engaging selectively with early investors and partners.
We look forward to connecting with you!